Multiple sclerosis drug may one day treat colorectal cancer

ScienceDaily - Health and Medicine News

After uncovering a mechanism that promotes chronic intestinal inflammation and the development of colorectal cancer, scientists have found that fingolimod, a drug currently approved for the treatment of multiple sclerosis, could potentially eliminate or reduce the progression of colitis-associated cancer.